Clostridioides difficileribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study

被引:34
作者
Azimirad, Masoumeh [1 ]
Krutova, Marcela [2 ,3 ,4 ]
Yadegar, Abbas [1 ]
Shahrokh, Shabnam [5 ]
Olfatifar, Meysam [5 ]
Aghdaei, Hamid Asadzadeh [6 ]
Fawley, Warren N. [4 ,7 ,8 ]
Wilcox, Mark H. [4 ,7 ,8 ]
Zali, Mohammad Reza [5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Foodborne & Waterborne Dis Res Ctr, Shahid Arabi Ave,Yemen St, Tehran, Iran
[2] Charles Univ Prague, Dept Med Microbiol, Fac Med 2, Prague, Czech Republic
[3] Motol Univ Hosp, Prague, Czech Republic
[4] Shahid Beheshti Univ Med Sci, European Soc Clin Microbiol & Infect Dis ESCMID, Study Grp Clostridioides Difficile ESGCD, Tehran, Iran
[5] Shahid Beheshti Univ Med Sci, Res Inst Gastroenterol & Liver Dis, Gastroenterol & Liver Dis Res Ctr, Tehran, Iran
[6] Shahid Beheshti Univ Med Sci, Basic & Mol Epidemiol Gastrointestinal Disorders, Res Inst Gastroenterol & Liver Dis, Tehran, Iran
[7] Leeds Teaching Hosp NHS Trust, Healthcare Associated Infect Res Grp, Leeds, W Yorkshire, England
[8] Univ Leeds, Leeds, W Yorkshire, England
关键词
Clostridioides difficile; ribotyping; Iran; CDI; epidemiology; clinical features; PaLoc arrangement; MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; INFECTION; PREVALENCE; STRAIN; TOXIN; DIAGNOSIS; EMERGENCE; AMERICA; SOCIETY;
D O I
10.1080/22221751.2020.1780949
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clostridioides difficileinfection (CDI) remains a major healthcare problem worldwide, however, little is known about CDI epidemiology in Iran. Between December 2004 and November 2018, 3649 stool samples were collected from patients in 69 hospitals and medical centres in Tehran and were cultured for the presence ofC. difficile; isolates were characterized by PCR ribotyping and toxin genes detection. A total of 582C. difficileisolates were obtained and the overall CDI prevalence was 15.9%; 290 (49.8%) cases were healthcare-associated (HA) and 292 (50.2%) cases were community-associated (CA). Of these, DNA of 513 isolates submitted for ribotyping. The ribotype and/or WEBRIBO type could be assessed in 366 (62.9%) isolates. The most frequent RTs were 001 (n = 75, 12.9%), 126 (n = 65, 11.2%) and 084 (n = 19, 3.3%); the toxin gene profiletcdA(+)B(+)/cdtA(+)B(+)(n = 112, 19.2%) was the most common. FifteenC. difficileisolates (2.6%) did not carry any toxin genes. There was no difference between frequently found RTs in HA-CDI and CA-CDI, except for RT 029 which was more likely to be associated with healthcare origin (12/15,p-value = 0.02). No isolate of RTs 027 or 078 was identified. Importantly, RTs 031, 038, 039, 084, 085 reported previously as RTs with an absence of toxin genes, revealed the presence of toxin genes in our study. Using Simpson's reciprocal index of diversity, we found that RT diversity decreased as the prevalence of the RT 084 increased (R = -0.78,p-value = 0.041). Different patterns in CDI epidemiology underscore the importance of local surveillance and infection control measures in Tehran healthcare settings.
引用
收藏
页码:1432 / 1443
页数:12
相关论文
共 60 条
[1]   A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole [J].
Adler, Amos ;
Miller-Roll, Tamar ;
Bradenstein, Rita ;
Block, Colin ;
Mendelson, Bracha ;
Parizade, Miriam ;
Paitan, Yossi ;
Schwartz, David ;
Peled, Nehama ;
Carmeli, Yehuda ;
Schwaber, Mitchell J. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (01) :21-24
[2]   Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study (vol 14, 502, 2014) [J].
Al-Thani, Asma A. ;
Hamdi, Wedad S. ;
Al-Ansari, Naser A. ;
Doiphode, Sanjay H. ;
Wilson, Godwin Justus .
BMC INFECTIOUS DISEASES, 2015, 15
[3]   Characterization of Clostridioides difficile isolates recovered from hospitalized patients and the hospitals environment and air: A multicenter study [J].
Aliramezani, Amir ;
Talebi, Malihe ;
Golbabaei, Farideh ;
Baghani, Akram ;
Marjani, Majid ;
Afhami, Shirin ;
Hajabdolbaghi, Mahbobeh ;
Boroumand, Mohammad Ali ;
Kuijper, Ed J. ;
Douraghi, Masoumeh .
ANAEROBE, 2019, 59 :154-158
[4]   Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease [J].
Azimirad, Masoumeh ;
Krutova, Marcela ;
Balaii, Hedieh ;
Kodori, Mansoor ;
Shahrokh, Shabnam ;
Azizi, Omid ;
Yadegar, Abbas ;
Aghdaei, Hamid Asadzadeh ;
Zali, Mohammad Reza .
ANAEROBE, 2020, 61
[5]   Infection with enterotoxigenic Staphylococcus aureus as a concern in patients with gastroenteritis [J].
Azimirad, Masoumeh ;
Dezfulian, Anahita ;
Alebouyeh, Masoud ;
Esfehani, Rasoul Bahreiny ;
Shahrokh, Shabnam ;
Zali, Mohammad Reza .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 9 :111-114
[6]   Clostridium difficile infection in Europe: a hospital-based survey [J].
Bauer, Martijn P. ;
Notermans, Daan W. ;
van Benthem, Birgit H. B. ;
Brazier, Jon S. ;
Wilcox, Mark H. ;
Rupnik, Maja ;
Monnet, Dominique L. ;
van Dissel, Jaap T. ;
Kuijper, Ed J. .
LANCET, 2011, 377 (9759) :63-73
[7]   Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon [J].
Berger, Fabian K. ;
Rasheed, Sari S. ;
Araj, George F. ;
Mahfouz, Rami ;
Rimmani, Hussein H. ;
Karaoui, Walid R. ;
Sharara, Ala I. ;
Dbaibo, Ghassan ;
Becker, Soeren L. ;
von Mueller, Lutz ;
Bischoff, Markus ;
Matar, Ghassan M. ;
Gartner, Barbara .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 308 (03) :358-363
[8]   Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories [J].
Burnham, Carey-Ann D. ;
Carroll, Karen C. .
CLINICAL MICROBIOLOGY REVIEWS, 2013, 26 (03) :604-630
[9]   Analysis of the pathogenicity locus in Clostridium difficile strains [J].
Cohen, SH ;
Tang, YJ ;
Silva, J .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :659-663
[10]  
Collins D. A., 2017, New Microbes and New Infections, V18, P34, DOI 10.1016/j.nmni.2017.04.006